Boston, MA 05/30/2014 (wallstreetpr) – According to recently published reports, a leading pharmaceutical company Boston Scientific Corporation (NYSE:BSX) is all set to acquire IoGyn, Inc. The details of the deal are as follow-
IoGyn, Inc vs BSX:
Recently there were rumors about the growth strategy of BSX in the market, and by making an announcement to enter into a definitive agreement with IoGyn Inc., the company has made its intentions pretty clear. Boston Scientific Corporation (NYSE:BSX) has announced to acquire IoGyn to strengthen its market share. Please note that IoGyn In. is known for its Symphion System in all overt the world. Symphion is an amazing next generation system which can be used for hysteroscopy intrauterine tissue removal.
Once the acquisition transaction is finished, and Boston Scientific Genesys HTA system is paired with Symphion System, both the companies will be able to execute abnormal uterine bleeding. It can further be utilized to create several gynecologic surgery products. The applications used at IoGyn will facilitate Boston Scientific Corporation (NYSE:BSX) to treat debilitating gynecologic conditions in such a way that their surgeons will use minimally-invasive approaches easily in their work. It will be very helpful in improving the life of women across the world.
The hysteroscopic approach of Symphion System is responsible for fast growth in uterus and also filtering the management system of fuel. Please note that scientists have noted an alternative yet effective approach to use fluid management system. Please note that BSX has estimated present hysteroscopic market of $80 million. If taken into consideration the forecast of market experts, one can see that there are excellent growth opportunities available in hysteroscopic market segment. According to a report, it will grow to $200 million in next six years.
After looking at the growth prospects in it, Boston Scientific Corporation (NYSE:BSX) has decided to make the maximum investment in the same segment, and acquiring IoGyn is the first step in the same direction.
